Allergic contact dermatitis from essential oil in consumer products: Mode of uses and value of patch tests with an essential oil series. Results of a French study of the DAG (Dermato-Allergology group of the French Society of Dermatology)

Annick Barbaud,Flore Kurihara,Nadia Raison-Peyron,Brigitte Milpied,Aude Valois,Haudrey Assier,Cécile Morice,Jean Romain Manciet,Gwendeline Gener,Françoise Giordano-Labadie,Pierre Marcant,Claire Bernier,Emmanuelle Amsler,Marie Noelle Crepy,Florence Tetart,Angèle Soria,Marie-Christine Ferrier le Bouëdec,Dermato-Allergology Group of the French Society of Dermatology (DAG)
DOI: https://doi.org/10.1111/cod.14377
Contact Dermatitis
Abstract:Objective: To analyse the clinical characteristics and sensitivity of an essential oil patch test series (EOS) in patients sensitized to their own essential oils (EOs). Method: We analysed the clinical data and patch test results obtained with the European baseline series (BSE) and an EOS, as well as the mode of use of EOs, through a questionnaire included in the patient file. Results: The study included 42 patients (79% women, average age 50 years) with allergic contact dermatitis (ACD), 8 patients required hospitalization. All patients were sensitized to the EO they used, primarily lavender (Lavandula augustifolia, 8000-28-0), tea tree (Melaleuca alternifolia leaf oil, 68647-73-4), ravintsara (Cinnamomum camphora oil, 92201-50-8), and 2 cases were attributed to helichrysum (helichrysum italicum flower absolute, 90045-56-0). 71% had positive patch tests to fragrance mix I or II, 9 only to the EOS and 4 only with their personal EO. Interestingly, 40% of patients did not spontaneously mention the use of EOs, and only 33% received advice on their use at the time of purchase. Conclusion: Patch tests with the BSE, limonene and linalool HP, and oxidized tea tree oil is sufficient to detect most EO-sensitized patients. The most important is to test the patient's own used EOs.
What problem does this paper attempt to address?